State Street’s Vigil Neuroscience VIGL Stock Holding History

State Street’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-109,399	Closed	-$870K	–	4380
2025 Q2	$870K	Buy	109,399 +40,260	+58%	+$180K	﹤0.01%	3516
2025 Q1	$123K	Hold	69,139	–	–	﹤0.01%	3925
2024 Q4	$118K	Buy	69,139 +28,400	+70%	+$83.9K	﹤0.01%	3961
2024 Q3	$139K	Hold	40,739	–	–	﹤0.01%	3910
2024 Q2	$163K	Sell	40,739 -245,324	-86%	-$840K	﹤0.01%	3870
2024 Q1	$975K	Buy	286,063 +2,772	+1%	+$8.65K	﹤0.01%	3477
2023 Q4	$958K	Buy	283,291 +5,678	+2%	+$29.2K	﹤0.01%	3488
2023 Q3	$1.5M	Buy	277,613 +17,914	+7%	+$124K	﹤0.01%	3427
2023 Q2	$2.44M	Buy	259,699 +223,960	+627%	+$2.12M	﹤0.01%	3319
2023 Q1	$350K	Hold	35,739	–	–	﹤0.01%	3870
2022 Q4	$447K	Buy	35,739 +14,365	+67%	+$176K	﹤0.01%	3806
2022 Q3	$195K	Buy	21,374 +3,000	+16%	+$22K	﹤0.01%	4154
2022 Q2	$47K	Sell	18,374 -36,105	-66%	-$143K	﹤0.01%	4737
2022 Q1	$383K	Buy	+54,479	New	+$719K	﹤0.01%	4147

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

State Street's VIGL Position: Q3 2025 in Review

State Street sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 109,399 shares — an estimated $870K sold.

State Street first reported a position in VIGL in Q1 2022 and held it in 14 quarters. The position peaked at $2.44M in Q2 2023. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

State Street reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
State Street sold 109,399 Vigil Neuroscience shares in Q3 2025, an estimated $870K.
State Street first reported a position in Vigil Neuroscience in Q1 2022 and held it in 14 quarters.
State Street's Vigil Neuroscience position peaked at $2.44M in Q2 2023.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on State Street's 13F filing for Q3 2025, filed 14 Nov 2025.